Number of Shares
225,100.00
Current Holdings Value*
$24.90 Mil
% of Portfolio
6.46%
Total Estimate Gain
$-716,757.00
% of Total Estimate Gain
-2.41%

Eagle Health Investments LP's Neurocrine Biosciences Inc Holding Summary

As of 2025-03-31, Eagle Health Investments LP held 225,100.00 shares of Neurocrine Biosciences Inc(NBIX), totaling $24.90 Mil. This investment constitutes 6.46% of their stock portfolio, and Eagle Health Investments LP now holds 0.23% of the outstanding Neurocrine Biosciences Inc(NBIX) stock.

The initial trade took place in 2024Q3. And since then Eagle Health Investments LP has made 3 purchases of NBIX, at an average price of $132.29, for a total of 225,100.00 shares. Based on historical transaction data and NBIX's current price of $129.11, Eagle Health Investments LP's estimated gain on his NBIX holdings is $-716,757.00, reflecting a -2.41% gain to date.

Eagle Health Investments LP NBIX ($129.11) Holding Chart

Eagle Health Investments LP NBIX ($129.11) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1